Align Technology/$ALGN
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About Align Technology
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Ticker
$ALGN
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
21,200
ISIN
US0162551016
Website
Align Technology Metrics
BasicAdvanced
$14B
35.82
$5.50
1.64
-
Price and volume
Market cap
$14B
Beta
1.64
52-week high
$263.24
52-week low
$141.74
Average daily volume
837K
Financial strength
Current ratio
1.206
Quick ratio
0.989
Long term debt to equity
2.279
Total debt to equity
2.279
Profitability
EBITDA (TTM)
807.307
Gross margin (TTM)
70.02%
Net profit margin (TTM)
10.29%
Operating margin (TTM)
16.55%
Effective tax rate (TTM)
30.70%
Revenue per employee (TTM)
$190,000
Management effectiveness
Return on assets (TTM)
6.72%
Return on equity (TTM)
10.84%
Valuation
Price to earnings (TTM)
35.818
Price to revenue (TTM)
3.685
Price to book
3.79
Price to tangible book (TTM)
4.45
Price to free cash flow (TTM)
23.258
Free cash flow yield (TTM)
4.30%
Free cash flow per share (TTM)
846.93%
Growth
Revenue change (TTM)
1.64%
Earnings per share change (TTM)
-9.32%
3-year revenue growth (CAGR)
-0.42%
10-year revenue growth (CAGR)
17.72%
3-year earnings per share growth (CAGR)
-14.77%
10-year earnings per share growth (CAGR)
11.69%
What the Analysts think about Align Technology
Analyst ratings (Buy, Hold, Sell) for Align Technology stock.
Align Technology Financial Performance
Revenues and expenses
Align Technology Earnings Performance
Company profitability
Align Technology News
AllArticlesVideos
Britt Vitalone Joins Align Technology Board of Directors
Business Wire·2 days ago
Align Technology to Announce Second Quarter 2025 Results on July 30, 2025
Business Wire·3 days ago
Align Technology Connects With Over 2,000 Doctors and Practice Staff at the 2025 Invisalign® Asia Pacific (APAC) Summit
Business Wire·7 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Align Technology stock?
Align Technology (ALGN) has a market cap of $14B as of July 04, 2025.
What is the P/E ratio for Align Technology stock?
The price to earnings (P/E) ratio for Align Technology (ALGN) stock is 35.82 as of July 04, 2025.
Does Align Technology stock pay dividends?
No, Align Technology (ALGN) stock does not pay dividends to its shareholders as of July 04, 2025.
When is the next Align Technology dividend payment date?
Align Technology (ALGN) stock does not pay dividends to its shareholders.
What is the beta indicator for Align Technology?
Align Technology (ALGN) has a beta rating of 1.64. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.